SEC FORM 4
$6,286.00
Travere Therapeutics, Inc. (TVTX)
Acquisition (code M) of 350 shares at $17.96 per share.
Reporting Person ROTE WILLIAM E. · Officer Title Chief Research Officer · Transaction Code M
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001698262-26-000005 · filed 2026-09-17 · View filing →